HKD103.10
0.68% today
Hong Kong, Aug 22, 10:00 am CET
ISIN
CNE1000031K4
Symbol
2359
Index

WuXi AppTec Stock price

HKD103.20
+11.55 12.60% 1M
+40.67 65.03% 6M
+47.03 83.73% YTD
+71.83 229.02% 1Y
+13.53 15.08% 3Y
+10.58 11.42% 5Y
+74.46 259.04% 10Y
+74.46 259.04% 20Y
Hong Kong, Closing price Fri, Aug 22 2025
+0.80 0.78%

Key metrics

Basic
Market capitalization
HKD281.0b
Enterprise Value
HKD265.6b
Net debt
positive
Cash
HKD27.4b
Shares outstanding
2.9b
Valuation (TTM | estimate)
P/E
19.6 | 23.4
P/S
6.0 | 5.9
EV/Sales
5.7 | 5.6
EV/FCF
23.8
P/B
4.3
Dividends
DPS
HKD1.82
Yield 1Y | 5Y
1.0% | 0.9%
Growth 1Y | 5Y
-2.2% | 28.2%
Payout 1Y | 3Y
50.9% | 38.2%
Increased
5 Years
Financials (TTM | estimate)
Revenue
HKD46.6b | HKD47.3b
EBITDA
- | HKD17.7b
EBIT
HKD13.2b | HKD14.7b
Net Income
HKD15.0b | HKD12.6b
Free Cash Flow
HKD11.2b
Growth (TTM | estimate)
Revenue
10.6% | 10.9%
EBITDA
- | 45.1%
EBIT
14.3% | 20.9%
Net Income
61.4% | 22.1%
Free Cash Flow
26.2%
Margin (TTM | estimate)
Gross
43.0%
EBITDA
- | 37.3%
EBIT
28.4%
Net
32.2% | 26.5%
Free Cash Flow
24.0%
Financial Health
Equity Ratio
73.0%
Return on Equity
16.1%
ROCE
19.2%
ROIC
20.5%
Debt/Equity
0.2
More
EPS
HKD5.2
FCF per Share
HKD3.9
Short interest
-
Employees
39k
Rev per Employee
HKD1.1m
Show more

Is WuXi AppTec a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,015 stocks worldwide.

WuXi AppTec Stock Analysis

Unlock Scores for Free

Analyst Opinions

23 Analysts have issued a WuXi AppTec forecast:

21x Buy
91%
2x Hold
9%

Analyst Opinions

23 Analysts have issued a WuXi AppTec forecast:

Buy
91%
Hold
9%

Financial data from WuXi AppTec

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
46,576 46,576
11% 11%
100%
- Direct Costs 26,541 26,541
5% 5%
57%
20,035 20,035
19% 19%
43%
- Selling and Administrative Expenses 4,427 4,427
9% 9%
10%
- Research and Development Expense 1,215 1,215
21% 21%
3%
- -
-
-
- Depreciation and Amortization - -
-
-
EBIT (Operating Income) EBIT 13,217 13,217
14% 14%
28%
Net Profit 14,986 14,986
61% 61%
32%

In millions HKD.

Don't miss a Thing! We will send you all news about WuXi AppTec directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

WuXi AppTec Co., Ltd. provides an integrated pharmaceutical platform for the research, development, and production of new drugs. It operates through the following business segments: Contract research organization (CRO) services, Contract manufacturing organization (CMO)/Contract development and manufacturing organization (CDMO) business, and Others. The CRO services segment includes laboratory services in China, laboratory services in the United States, and clinical research services. The company was founded by Ge Li, Ning Zhao, Xiao Zhong Liu, Zhao Hui Zhang, and Tao Lin on December 1, 2000 and is headquartered in Shanghai, China.

Head office China
CEO Min Chen
Employees 39,414
Founded 2000
Website www.wuxiapptec.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today